Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS MONTH'S ISSUE:
July 2016

Drugs to Facilitate Smoking Cessation
A growing number of pharmacologic options, including nicotine-replacement therapies, are available to help people quit smoking cigarettes.

Antipsychotics and Mortality in Parkinson Disease
In a recent study of patients with Parkinson disease, treatment with an antipsychotic was associated with a twofold increase in the risk of death.

In Brief
Increased Energy Output from Physical Activity Linked to Larger Gray Matter Volumes in Elderly; Psilocybin Shows Benefit for Treatment-Resistant Depression in Small Open-Label Trial

Anti-inflammatory Agents as Adjuncts against Bipolar Depression
In a systematic review of clinical trials employing adjunctive anti-inflammatory agents to treat bipolar depression, investigators found a statistically significant antidepressant benefit.

Continuing Medical Education credits available!

Now provided by The CME Institute of Physicians Postgraduate Press, Inc. After reading this volume of Biological Therapies in Psychiatry (BTP), the learner will be able to (1) discuss new psychiatric drugs, including side effects and drug interactions, and (2) describe new information on older medications and new biological treatments.

The CME Institute of Physicians Postgraduate Press, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The CME Institute of Physicians Postgraduate Press, Inc., designates this enduring material for a maximum of 12 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The CME posttest will be provided with the December 2016 issue of BTP. To obtain credit, you must answer 18 of 24 questions correctly and return the answer sheet to the CME Institute of Physicians Postgraduate Press, Inc., by March 31, 2017. The cost for this activity is $30.